Table 2.
Clinical characteristics of AIH patients.
| Clinical presentations, n (%) | n (%) |
|---|---|
| Asthenia | 33 (66) |
| Arthralgia | 10 (20) |
| Nausea | 8 (16) |
| Anorexia | 10 (20) |
| Weight loss | 13 (26) |
| Abdominal pain | 13 (26) |
| Jaundice | 40 (80.0) |
| Pruritus | 23 (46) |
| Splenomegaly | 26 (52) |
| Hepatomegaly | 17 (34) |
| Antibodies presence, n (%) | |
| ANA | 35 (70) |
| SMA | 29 (58) |
| LKM1 | 2 (4) |
| SLA | 2 (4) |
| AMA-M2 | 11 (22) |
| Infections, n (%) | |
| EBV infection | 1 (3.3) |
| CMV infection | 3 (6) |
ANA: anti-nuclear antibodies, SMA: Smooth-muscle antibodies, LKM1: Anti-Liver/Kidney Microsomal Antibodies Type 1, SLA: Antibodies against soluble liver antigen, AMA-M2: Anti-mitochondrial antibody-M2, EBV: Epstein–Barr virus, CMV: Cytomegalovirus, NA: not applicable.